Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 52,439 | 32,830 | 20,021 | 20,375 | 15,693 |
| Operating Income | -52,439 | -32,830 | -20,021 | -20,375 | -15,693 |
| Interest Expense | 1,295 | 1,286 | 1,262 | 738 | 1,039 |
| Other Income | 13 | 11 | 182 | 972 | -81,274 |
| Pre-tax Income | -53,721 | -34,105 | -21,101 | -20,141 | -98,006 |
| Net Income Continuous | -53,721 | -34,105 | -21,101 | -20,141 | -98,006 |
| Net Income | $-53,721 | $-34,105 | $-21,101 | $-20,141 | $-98,006 |
| EPS Basic Total Ops | -1.60 | -1.02 | -0.64 | -0.62 | 0.15 |
| EPS Basic Continuous Ops | -1.60 | -1.02 | -0.64 | -0.62 | 0.15 |
| EPS Diluted Total Ops | -1.60 | -1.02 | -0.64 | -0.62 | 0.15 |
| EPS Diluted Continuous Ops | -1.60 | -1.02 | -0.64 | -0.62 | 0.15 |
| EBITDA(a) | $-51,964 | $-32,382 | $-19,599 | $-20,124 | $-15,521 |